Skip to main content
INSAN Inc. logo

INSAN Inc. — Investor Relations & Filings

Ticker · 277410 ISIN · KR7277410007 KO Manufacturing
Filings indexed 326 across all filing types
Latest filing 2022-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 277410

About INSAN Inc.

https://en.insan.com/

INSAN Inc. is a manufacturer and distributor of health food and bio-medical products based on traditional Korean principles. The company specializes in the production and global sale of its flagship product, Insan Bamboo Salt®, a unique mineral-refined salt. Its product portfolio extends to a range of bamboo salt application foods, including fermented pastes and sauces, as well as health supplements such as pills, capsules, and extracts. The company also offers personal care items and other products derived from native plants.

Recent filings

Filing Released Lang Actions
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 인산가' (Insan Inc.) covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business descriptions, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and major contracts (such as collateral agreements) of the company's largest shareholder and their special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-11-07 Korean
[기재정정]신규시설투자등
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Insanga) regarding a 'New Facility Investment' (신규시설투자). It details a correction (정정신고) to a previously filed investment report, updating the final investment amount following the completion of construction. This type of disclosure regarding capital expenditure and facility investment does not fit into specific categories like dividends, M&A, or earnings, and is best classified as a general regulatory filing.
2022-09-30 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price (Refixing) for convertible bonds (CB) issued by Insanga. It details the change in conversion price, the number of convertible shares, and the calculation methodology based on market price fluctuations. This type of disclosure is a standard capital structure update related to financing instruments, which falls under the 'Capital/Financing Update' category.
2022-09-08 Korean
[기재정정]신규시설투자등
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Insanga) regarding a 'New Facility Investment' (신규시설투자). It details a correction (정정신고) to a previous disclosure concerning investment amounts, project timelines, and design changes for a specific industrial complex. Since this is a specific corporate disclosure regarding capital expenditure and facility investment updates, it falls under the 'Capital/Financing Update' category.
2022-08-31 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company '주식회사 인산가' (Insan Inc.) covering the period from January 1, 2022, to June 30, 2022. It contains detailed financial information, business descriptions, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.